Literature DB >> 225554

Selective assay for herpes simplex viruses expressing thymidine kinase.

J Campione-Piccardo, W E Rawls, S Bacchetti.   

Abstract

A technique for selecting herpes simplex viruses expressing the viral thymidine kinase (TK+) from a population of predominantly TK- viruses was developed. This was accomplished by infecting TK- cells and incubating the cultures under a liquid overlay medium containing methotrexate. Since the TK- cells survive in this medium for only a limited period of time, it was necessary to add fresh uninfected TK- cells 48 h after infection. The technique allowed the detection and quantitation of the TK+ virus fraction in mixtures of TK+ and TK- viruses where the TK+ fraction was present in frequencies as low as 10(-5). It was also used to estimate reversion frequencies and to obtain and analyze TK+ revertants from TK- mutant strains of herpes simplex virus type 1.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225554      PMCID: PMC353450     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  MUTANT STRAINS OF HERPES SIMPLEX DEFICIENT IN THYMIDINE KINASE-INDUCING ACTIVITY.

Authors:  D R DUBBS; S KIT
Journal:  Virology       Date:  1964-04       Impact factor: 3.616

2.  RELATIONSHIP BETWEEN THE ENVELOPE AND THE INFECTIVITY OF HERPES SIMPLEX VIRUS.

Authors:  K O SMITH
Journal:  Proc Soc Exp Biol Med       Date:  1964-03

3.  Studies on unbalanced growth in tissue culture. I. Induction and consequences of thymidine deficiency.

Authors:  R R RUECKERT; G C MUELLER
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

4.  Physical mapping of herpes simplex virus type 1 mutations by marker rescue.

Authors:  N D Stow; J H Subak-Sharpe; N M Wilkie
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

5.  Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.

Authors:  M Wigler; S Silverstein; L S Lee; A Pellicer; Y c Cheng; R Axel
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

6.  The transfer and stable integration of the HSV thymidine kinase gene into mouse cells.

Authors:  A Pellicer; M Wigler; R Axel; S Silverstein
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

7.  Introduction of the herpes simplex virus thymidine kinase gene into mouse cells using virus DNA or transformed cell DNA.

Authors:  A C Minson; P Wildy; A Buchan; G Darby
Journal:  Cell       Date:  1978-03       Impact factor: 41.582

8.  Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

9.  [125I]deoxycytidine used in a rapid, sensitive, and specific assay for herpes simplex virus type 1 thymidine kinase.

Authors:  W C Summers; W P Summers
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

10.  Biochemical transformation of mouse cells by fragments of herpes simplex virus DNA.

Authors:  N J Maitland; J K McDougall
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

View more
  25 in total

1.  Generation of hybrid genes and proteins by vaccinia virus-mediated recombination: application to human immunodeficiency virus type 1 env.

Authors:  L Gritz; A Destree; N Cormier; E Day; V Stallard; T Caiazzo; G Mazzara; D Panicali
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

2.  Utilization of DNA recombination for the two-step replacement of growth factor sequences in the vaccinia virus genome.

Authors:  D D Spyropoulos; V Stallard; B E Roberts; L K Cohen
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

3.  Delineation of the viral products of recombination in vaccinia virus-infected cells.

Authors:  D D Spyropoulos; B E Roberts; D L Panicali; L K Cohen
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

4.  Characterization of virulent and attenuated strains of pseudorabies virus for thymidine kinase activity, virulence and restriction patterns.

Authors:  M D McFarland; H T Hill; L B Tabatabai
Journal:  Can J Vet Res       Date:  1987-07       Impact factor: 1.310

5.  Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components.

Authors:  M F Stinski; T J Roehr
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

6.  Herpes simplex virus 1 recombinants with noninverting genomes frozen in different isomeric arrangements are capable of independent replication.

Authors:  F J Jenkins; B Roizman
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

7.  Comparative methods for detection of thymidine kinase-deficient herpes simplex virus type 1 strains.

Authors:  J Harmenberg; V A Sundqvist; H Gadler; B Levén; G Brännström; B Wahren
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

8.  In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus.

Authors:  E L Hill; G A Hunter; M N Ellis
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

9.  Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA.

Authors:  J P Weir; G Bajszár; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

10.  Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.

Authors:  D Panicali; E Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.